Inventor · disambiguated record
Maghsoud M. Dariani
Also filed as: DARIANI MAGHSOUD · DARIANI MAGHSOUD M
17 granted patents·19 pending applications·1,348 citations·filing 1997–2024
95Inventor score
Top patents by PatentIndex Score
36 records- 0198US5837284ADelivery of multiple doses of medicationsFiled 1997·Granted Nov 17, 1998·552 cites·30 claims
- 0297US6528530B2Phenidate drug formulations having diminished abuse potentialCELGENE CORP·Filed 2001·Granted Mar 4, 2003·132 cites·4 claims
- 0397US6355656B1Phenidate drug formulations having diminished abuse potentialCELGENE CORP·Filed 1999·Granted Mar 12, 2002·147 cites·4 claims
- 0496US5908850AMethod of treating attention deficit disorders with d-threo methylphenidateCELGENE CORP·Filed 1997·Granted Jun 1, 1999·211 cites·4 claims
- 0595US7431944B2Delivery of multiple doses of medicationsCELGENE CORP·Filed 2003·Granted Oct 7, 2008·49 cites·6 claims
- 0695US6255325B1Chronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 1999·Granted Jul 3, 2001·53 cites·1 claims
- 0794US6602887B2Chronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 2001·Granted Aug 5, 2003·28 cites·8 claims
- 0893US7115631B2Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2002·Granted Oct 3, 2006·39 cites·56 claims
- 0992US6635284B2Delivery of multiple doses of medicationsCELGENE CORP·Filed 1998·Granted Oct 21, 2003·102 cites·11 claims
- 1083US5922736AChronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 1997·Granted Jul 13, 1999·34 cites·10 claims
- 1180US2010035928A1Method Of Treating Attention Deficit Disorders With D-Threo MethylphenidateZEITLIN ANDREW L·Filed 2009·Application pending·0 cites
- 1278US12251405B2Spray dried follistatin productMYOS RENS TECH INC·Filed 2018·Granted Mar 18, 2025·1 cites·6 claims
- 1378US2009088455A1Chronic, Bolus Adminstration Of D-Threo MethylphenidateCELGENE CORP·Filed 2008·Application pending·0 cites
- 1476US12478656B2Methods and compositions for improving quality of life and increasing activity in aging and chronically ill mammalsMYOS CORP·Filed 2023·Granted Nov 25, 2025·0 cites·3 claims
- 1571US12344583B2Solid psilocin saltsLOBE SCIENCES LTD·Filed 2024·Granted Jul 1, 2025·0 cites·12 claims
- 1670US2010093797A1Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo MethylphenidateZELDIS JEROME B·Filed 2009·Application pending·0 cites
- 1769US2006030587A1Method of treating attention deficit disorders with d-threo methylphenidateCELGENE CORP·Filed 2005·Application pending·0 cites
- 1869US2005119307A1Method of treating attention deficit disorders with D-threo methylphenidateCELGENE CORP·Filed 2004·Application pending·0 cites
- 1967US10925904B2Methods and compositions for improving skeletal muscle protein fractional synthetic rateMYOS RENS TECH INC·Filed 2019·Granted Feb 23, 2021·0 cites·1 claims
- 2067US2013109719A1Method of treating attention deficit disorders with d-threo methylphenidateZEITLIN ANDREW L·Filed 2012·Application pending·0 cites
- 2166US2011201645A1Method Of Treating Attention Deficit Disorders With D-Threo MethylphenidateZEITLIN ANDREW L·Filed 2011·Application pending·0 cites
- 2265US2005049279A1Chronic, bolus administration of D-threo methylphenidateCELGENE CORP·Filed 2004·Application pending·0 cites
- 2364US2025084378A1Nonhuman stem cells and their use for production of cultured meatATELIER MEATS CORP·Filed 2022·Application pending·0 cites
- 2462US11318171B2Methods and compositions for improving skeletal muscle protein fractional synthetic rateMYOS RENS TECH INC·Filed 2020·Granted May 3, 2022·0 cites·6 claims
- 2561US2013053414A1Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidateZELDIS JEROME B·Filed 2012·Application pending·0 cites
- 2661US2003232857A1Chronic, bolus administration of D-threo methylphenidateFiled 2003·Application pending·0 cites
- 2760US11833186B2Methods and compositions for improving quality of life and increasing activity in aging and chronically ill mammalsMYOS CORP·Filed 2020·Granted Dec 5, 2023·0 cites·7 claims
- 2860US2024099342A1Muscle enhancing productsMYOS CORP·Filed 2020·Application pending·0 cites
- 2959US12246042B2Methods for alleviating, inhibiting or reversing muscle disuse atrophy in mammalsMYOS CORP·Filed 2019·Granted Mar 11, 2025·0 cites·9 claims
- 3059US2006183774A1Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2006·Application pending·0 cites
- 3158US2011257227A1Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo MethylphenidateZELDIS JEROME B·Filed 2011·Application pending·0 cites
- 3255US2023218570A1Methods and Compositions for Treating Mild Traumatic Brain Injury, Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress DisorderLOBE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 3351US2022370511A1Methods and compositions for enhancing overall health and longevity in mammalsMYOS CORP·Filed 2020·Application pending·0 cites
- 3450US2023157981A1Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress DisorderLOBE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 3549US2021379117A1Methods for alleviating post-polio muscle weakness and conditions similar theretoMYOS RENS TECH INC·Filed 2021·Application pending·0 cites
- 3649US2021030840A1Methods and Compositions for Improving Quality of Life and Increasing Activity in Aging and Chronically Ill MammalsMYOS RENS TECH INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maghsoud M. Dariani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →